journal article·2019-12-04Open access

Vascular protection of salicin on IL-1β-induced endothelial inflammatory response and damages in retinal endothelial cells

Yu Song, Xia Tian, Xuehong Wang, Hui Feng

Abstract

Retinal endothelial cells (RECs) are involved in many ocular diseases such as age-related macular degeneration (AMD) and diabetic retinopathy. Salicin is the major ingredient of willow bark extract, and it has been shown to be a potent anti-inflammatory agent. We aim to explore whether salicin has a vascular protective effect in RECs. Our data indicate that the presence of salicin in RECs culture media ameliorates interleukin-1β (IL-1β)-induced cellular reactive oxygen species (ROS) production and NADPH oxidase 4 (NOX-4) expression. At the cellular level, salicin attenuates IL-1β-induced mitochondrial injury as revealed by its preservation on mitochondrial membrane potential (MMP). Furthermore, salicin inhibits IL-1β-induced production of pro-inflammatory cytokines such as tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), and monocyte chemoattractant protein-1 (MCP-1), vascular adhesion molecules such as intercellular cell adhesion molecule-1 (iCAM-1) and vascular cell adhesion molecule 1 (VCAM-1), and high-mobility group protein 1 (HMGB-1). On the other hand, salicin recovers IL-1β-induced reduction of endothelial nitric oxide synthase (eNOS) and nitric oxide (NO) release. The presence of salicin significantly reduces the IL-1β-induced release of lactate dehydrogenase (LDH), indicating that it mitigates cytokine caused cytotoxicity. Mechanistically, we show that salicin suppresses IL-1β-induced activation of the nuclear factor-kappa B (NF-κB) signaling as revealed by its suppression on nuclear p65 protein and transfected NF-κB promoter. Collectively, our study demonstrates by multiple facets of its mechanisms that salicin is a protective agent in retinal endothelial cells. These results imply its potential use in therapeutic usage of retinal disease.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Retinal Diseases and Treatments · Glaucoma and retinal disorders · Retinal Imaging and Analysis

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of ophthalmology, Weihai Central hospital

References (21)

Show source-provided references
1. 10.5301/EJO.2010.604910.5301/EJO.2010.6049 ↗
2. 10.1007/978-3-540-29542-6_810.1007/978-3-540-29542-6_8 ↗
3. 10.1016/S0140-6736(18)31550-210.1016/S0140-6736(18)31550-2 ↗
4. 10.1097/ICU.000000000000036210.1097/ICU.0000000000000362 ↗
5. Whitmore SS, Braun TA, Skeie JM, et al. Altered gene expression in dry age-related macular degeneration suggests early loss of choroidal endothelial cells. Mol Vis. 2013;19:2274–2297.
6. 10.17925/USOR.2017.10.02.11910.17925/USOR.2017.10.02.119 ↗
7. 10.3390/ijms1904094210.3390/ijms19040942 ↗
8. 10.1002/ptr.274710.1002/ptr.2747 ↗
9. 10.1016/S0009-9236(03)00116-410.1016/S0009-9236(03)00116-4 ↗
10. 10.1016/j.intimp.2015.04.01610.1016/j.intimp.2015.04.016 ↗
11. 10.1007/s00011-013-0685-110.1007/s00011-013-0685-1 ↗
12. 10.1080/21691401.2019.158028610.1080/21691401.2019.1580286 ↗
13. 10.1080/21691401.2019.159385710.1080/21691401.2019.1593857 ↗
14. 10.1007/s12192-016-0735-z10.1007/s12192-016-0735-z ↗
15. 10.1021/np500177u10.1021/np500177u ↗
16. 10.1016/j.phymed.2011.08.06510.1016/j.phymed.2011.08.065 ↗
17. 10.1055/s-0030-127072210.1055/s-0030-1270722 ↗
18. 10.1002/ptr.512610.1002/ptr.5126 ↗
19. 10.1016/j.freeradbiomed.2012.12.00610.1016/j.freeradbiomed.2012.12.006 ↗
20. 10.1161/01.CIR.0000105680.92873.7010.1161/01.CIR.0000105680.92873.70 ↗
21. 10.2119/molmed.2014.0006310.2119/molmed.2014.00063 ↗